TGF-β inhibits muscle differentiation by blocking autocrine signaling pathways initiated by IGF-II

Molecular Endocrinology

Volumn 25, Issue 1, 2011, Pages 128-137

  Gardner, Samantha ^a   Alzhanov, Damir ^a   Knollman, Paul ^a   Kuninger, David ^a   Rotwein, Peter ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECAPENTAPLEGIC PROTEIN; MESSENGER RNA; MYOSTATIN; SMAD3 PROTEIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; AUTOCRINE EFFECT; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; GENE DISRUPTION; GENE EXPRESSION; GENE INDUCTION; GENE TARGETING; HORMONE INHIBITION; HUMAN; HUMAN CELL; MOTHER; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE MASS; MUSCLE REGENERATION; MUSCLE STRENGTH; MYOBLAST; MYOTUBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; AUTOCRINE COMMUNICATION; CELL DIFFERENTIATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MICE; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; MYOBLASTS; SUS SCROFA; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 78650864449     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0292     Document Type: Article

References (64)

1. Palacios D, Puri PL 2006 The epigenetic network regulating muscle development and regeneration. J Cell Physiol 207: 1-11
2. Tapscott SJ 2005 The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development 132: 2685-2695
3. McKinsey TA, Zhang CL, Olson EN 2002 MEF2: A calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci 27: 40-47
4. Nakae J, Kido Y, Accili D 2001 Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev 22: 818-835
5. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75: 59-72
6. Coleman ME, DeMayo F, Yin KC, Lee HM, Geske R, Montgomery C, Schwartz RJ 1995 Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem 270: 12109-12116
7. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL 1998 Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA 95: 15603-15607
8. Paul AC, Rosenthal N 2002 Different modes of hypertrophy in skeletal muscle fibers. J Cell Biol 156: 751-760
9. Lee S, Barton ER, Sweeney HL, Farrar RP 2004 Viral expression of insulin-like growth factor-I enhances muscle hypertrophy in resistance- trained rats. J Appl Physiol 96: 1097-1104
10. Barton ER, Morris L, Musaro A, Rosenthal N, Sweeney HL 2002 Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 157: 137-148
11. Van Laere AS, Nguyen M, Braunschweig M, Nezer C, Collette C, Moreau L, Archibald AL, Haley CS, Buys N, TallyM,Andersson G, Georges M, AnderssonL2003Aregulatory mutation inIGF2causes a majorQTL effect on muscle growth in the pig. Nature 425: 832-836
12. Markljung E, Jiang L, Jaffe JD, Mikkelsen TS, Wallerman O,Larhammar M, Zhang X, Wang L, Saenz-Vash V, Gnirke A, Lindroth AM, BarrésR, Yan J, Strömberg S, De S, Pontén F, Lander ES, Carr SA, Zierath JR, Kullander K, Wadelius C, Lindblad-Toh K, Andersson G, Hjälm G, Andersson L 2009 ZBED6, a novel transcription factor derived from a domesticated DNA transposon regulates IGF2 expression and muscle growth. PLoS Biol 7: E1000256
13. Butter F, Kappei D, Buchholz F, Vermeulen M, Mann M 2010 A domesticated transposon mediates the effects of a single-nucleotide polymorphism responsible for enhanced muscle growth. EMBO Rep 11: 305-311
14. Glass DJ 2003 Molecular mechanisms modulating muscle mass. Trends Mol Med 9: 344-350
15. Wilson EM, Hsieh MM, Rotwein P 2003 Autocrine growth factor signaling by insulin-like growth factor-II mediates MyoD-stimulated myocyte maturation. J Biol Chem 278: 41109-41113
16. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ 2001 Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/ GSK3 pathways. Nat Cell Biol 3: 1009-1013
17. Lai KM, Gonzalez M, Poueymirou WT, Kline WO, Na E, Zlotchenko E, Stitt TN, Economides AN, Yancopoulos GD, Glass DJ 2004 Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol 24: 9295-9304
18. Massagué J, Cheifetz S, Endo T, Nadal-Ginard B 1986 Type β transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci USA 83: 8206-8210 (Pubitemid 17182470)
19. Kollias HD, McDermott JC 2008 Transforming growth factor-β and myostatin signaling in skeletal muscle. J Appl Physiol 104: 579-587
20. Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS, Khurana TS 2002 Functional improvement of dystrophic muscle by myostatin blockade. Nature 420: 418-421
21. Carlson ME, Hsu M, Conboy IM 2008 Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 454: 528-532
22. Carlson ME, Suetta C, Conboy MJ, Aagaard P, Mackey A, Kjaer M, Conboy I 2009 Molecular aging and rejuvenation of human muscle stem cells. EMBO Mol Med 1: 381-391
23. McFarlane C, Sharma M, Kambadur R 2008 Myostatin is a procachectic growth factor during postnatal myogenesis. Curr Opin Clin Nutr Metab Care 11: 422-427
24. Chen Y, Sood S, Biada J, Roth R, Rabkin R 2008 Increased work- load fully activates the blunted IRS-1/PI3-kinase/Akt signaling pathway in atrophied uremic muscle. Kidney Int 73: 848-855
25. Massagué J, Seoane J, Wotton D 2005 Smad transcription factors. Genes Dev 19: 2783-2810
26. Feng XH, Derynck R 2005 Specificity and versatility in tgf-β signaling through Smads. Annu Rev Cell Dev Biol 21: 659-693
27. Song K, Cornelius SC, Reiss M, Danielpour D 2003 Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-β by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2. J Biol Chem 278: 38342-38351
28. Song K, Wang H, Krebs TL, Danielpour D 2006 Novel roles of Akt and mTOR in suppressing TGF-β/ALK5-mediated Smad3 activation. EMBO J 25: 58-69
29. Remy I, Montmarquette A, MichnickSW2004 PKB/Akt modulates TGF-β signalling through a direct interaction with Smad3. Nat Cell Biol 6: 358-365
30. Florini JR, Magri KA, Ewton DZ, James PL, Grindstaff K, Rotwein PS 1991 "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J Biol Chem 266: 15917-15923
31. Wilson EM, Rotwein P 2006 Control of MyoD function during initiation of muscle differentiation by an autocrine signaling pathway activated by insulin-like growth factor-II. J Biol Chem 281: 29962-29971
32. Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, Kambadur R 2002 Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 277: 49831-49840
33. Trendelenburg AU, Meyer A, Rohner D, Boyle J, Hatakeyama S, Glass DJ 2009 Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. Am J Physiol Cell Physiol 296: C1258-C1270
34. Massagué J 1998 TGF-β signal transduction. Annu Rev Biochem 67: 753-791
35. Wrana JL, Attisano L, Cárcamo J, Zentella A, Doody J, Laiho M, Wang XF, Massagué J 1992 TGF-β signals through a heteromeric protein kinase receptor complex. Cell 71: 1003-1014
36. Firth SM, Baxter RC 2002 Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23: 824-854
37. Verrecchia F, Chu ML, Mauviel A 2001 Identification of novel TGF-β/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 276: 17058-17062
38. Hwa V, Oh Y, Rosenfeld RG 1997 Insulin-like growth factor binding protein-3 and -5 are regulated by transforming growth factor-β and retinoic acid in the human prostate adenocarcinoma cell line PC-3. Endocrine 6: 235-242
39. Rousse S, Lallemand F, Montarras D, Pinset C, Mazars A, Prunier C, Atfi A, Dubois C 2001 Transforming growth factor-β inhibition of insulin-like growth factor-binding protein-5 synthesis in skeletal muscle cells involves a c-Jun N-terminal kinase-dependent pathway. J Biol Chem 276: 46961-46967
40. Kou K, Rotwein P 1993 Transcriptional activation of the insulinlike growth factor-II gene during myoblast differentiation. Mol Endocrinol 7: 291-302
41. Duguay SJ, Jin Y, Stein J, Duguay AN, Gardner P, Steiner DF 1998 Post-translational processing of the insulin-like growth factor-2 precursor. Analysis of O-glycosylation and endoproteolysis. J Biol Chem 273: 18443-18451
42. Alzhanov DT, McInerney SF, Rotwein P 11 October 2010 Long-range interactions regulate Igf2 gene transcription during skeletal muscle differentiation. J Biol Chem 285 10.1074/jbc.M110.160986
43. Florini JR, Ewton DZ, Magri KA 1991 Hormones, growth factors, and myogenic differentiation. Annu Rev Physiol 53: 201-216
44. McLennan IS, Koishi K 2002 The transforming growth factor-βs: Multifaceted regulators of the development and maintenance of skeletal muscles, motoneurons and Schwann cells. Int J Dev Biol 46: 559-567
45. Vaidya TB, Rhodes SJ, Taparowsky EJ, Konieczny SF 1989 Fibroblast growth factor and transforming growth factor β repress transcription of the myogenic regulatory gene MyoD1. Mol Cell Biol 9: 3576-3579
46. Wilson EM, Rotwein P 2007 Selective control of skeletal muscle differentiation by Akt1. J Biol Chem 282: 5106-5110
47. Liu D, Black BL, Derynck R 2001 TGF-β inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev 15: 2950-2966
48. Liu D, Kang JS, Derynck R 2004 TGF-β-activated Smad3 represses MEF2-dependent transcription in myogenic differentiation. EMBO J 23: 1557-1566
49. Sartori R, Milan G, Patron M, Mammucari C, Blaauw B, Abraham R, SandriM2009 Smad2 and 3 transcription factors control muscle mass in adulthood. Am J Physiol Cell Physiol 296: C1248-C1257
50. McFarlane C, Plummer E, Thomas M, Hennebry A, Ashby M, Ling N, Smith H, Sharma M, Kambadur R 2006 Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-κB-independent, FoxO1-dependent mechanism. J Cell Physiol 209: 501-514
51. Morissette MR, Cook SA, Buranasombati C, Rosenberg MA, Rosenzweig A 2009 Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt. Am J Physiol Cell Physiol 297: C1124-C1132
52. Amirouche A, Durieux AC, Banzet S, Koulmann N, Bonnefoy R, Mouret C, Bigard X, Peinnequin A, Freyssenet D 2009 Downregulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle. Endocrinology 150: 286-294
53. Lamouille S, Derynck R 2007 Cell size and invasion in TGF-β- induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol 178: 437-451
54. Guo YS, Townsend Jr CM, Jin GF, Beauchamp RD, Thompson JC 1995 Differential regulation by TGF-β1 and insulin of insulin-like growth factor binding protein-2 in IEC-6 cells. Am J Physiol 268: E1199-E1204
55. Kveiborg M, Flyvbjerg A, Eriksen EF, KassemM2001 Transforming growth factor-β1 stimulates the production of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in human bone marrow stromal osteoblast progenitors. J Endocrinol 169: 549-561 (Pubitemid 32536988)
56. Gonzalez C,Auw Yang KG, Schwab JH, Fitzsimmons JS, ReinholzMM, Resch ZT, Bale LK, Clemens VR, Conover CA, O'Driscoll SW, Reinholz GG 2010 Transforming growth factor-β1 modulates insulin-like growth factor binding protein-4 expression and proteolysis in cultured periosteal explants. Growth Horm IGF Res 20: 81-86
57. Edwards CA, Ferguson-Smith AC 2007 Mechanisms regulating imprinted genes in clusters. Curr Opin Cell Biol 19: 281-289
58. Wallace JA, Felsenfeld G 2007 We gather together: Insulators and genome organization. Curr Opin Genet Dev 17: 400-407
59. Phillips JE, Corces VG 2009 CTCF: Master weaver of the genome. Cell 137: 1194-1211
60. Bergström R, Savary K, Morén A, Guibert S, Heldin CH, Ohlsson R, Moustakas A 2010 Transforming growth factor β promotes complexes between Smad proteins and the CCCTC-binding factor on the H19 imprinting control region chromatin. J Biol Chem 285: 19727-19737
61. Band AM, Björklund M, Laiho M 2009 The phosphatidylinositol 3-kinase/Akt pathway regulates transforming growth factor-β signaling by destabilizing ski and inducing Smad7. J Biol Chem 284: 35441-35449
62. Kollias HD, Perry RL, Miyake T, Aziz A, McDermott JC 2006 Smad7 promotes and enhances skeletal muscle differentiation. Mol Cell Biol 26: 6248-6260
63. Miyake T, Alli NS, McDermott JC 2010 Nuclear function of Smad7 promotes myogenesis. Mol Cell Biol 30: 722-735
64. Yaffe D, Saxel O 1977 Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725-727